Docking and scoring in virtual screening for drug discovery: methods and applications; Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors; Integration of virtual and high-throughput screening; B7-H4, a molecule of the B7 family, negatively regulates T cell immunity; The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome; Polypharmacology: challenges and opportunities in drug discovery: miniperspective; Immune regulation by CD40 and its ligand GP39; Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties; Molecular similarity in medicinal chemistry: miniperspective; Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches; QSAR without borders; Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction; Application of Generative Autoencoder in De Novo Molecular Design; Complementarity determining region 1 (CDR1)-and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.; Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation; The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association; Exploring activity cliffs in medicinal chemistry: miniperspective; Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell; Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions; Selected concepts and investigations in compound classification, molecular descriptor analysis, and virtual screening
